How do universities move promising discoveries out of the lab and into the market? In this episode of BioTalk, Tatiana Litvin-Vechnyak, Vice President of Georgetown's Office of Technology Commercialization, Christon Hill, Program Manager for Georgetown Tech Ventures, and Jennifer Butler, Entrepreneur-in-Residence with BioHealth Innovation, discuss how Georgetown is building a stronger pipeline from academic science to startup formation. The conversation examines how Georgetown's commercialization efforts are evolving, how GTV supports faculty founders, and why structured programming, outside expertise, and stronger ecosystem connections matter for turning research into real-world impact.

The discussion also explores the "missing middle" between discovery and commercialization, the role of Entrepreneurs-in-Residence in advancing founders and technologies, and how partnerships among Georgetown, GTV, and BioHealth Innovation are helping to create a more durable and commercially focused innovation pipeline. The guests also reflect on Georgetown's place within the BioHealth Capital Region and what success will look like as the university continues building a stronger culture of entrepreneurship and company creation.

Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com).

Tatiana Litvin-Vechnyak, Ph.D., is Vice President of Georgetown's Office of Technology Commercialization, where she leads the university's efforts to translate research discoveries into real-world impact through licensing, startup creation, and innovation support. Since joining Georgetown in 2023, she has helped expand the university's commercialization infrastructure, including securing the U.S. Economic Development Administration Build to Scale grant that launched Georgetown Tech Ventures. With more than 20 years of experience in intellectual property, licensing, and business development, she previously served in leadership roles at Rutgers University, where she helped advance major innovation and venture development initiatives. She holds a Ph.D. in Pharmacology and is a Registered Patent Agent.

Christon Hill is Program Manager for Georgetown Tech Ventures in Georgetown University's Office of Technology Commercialization, where he develops programs, partnerships, and founder support pathways that help move promising research toward venture creation, strategic partnerships, and real-world use. With an interdisciplinary background spanning biotechnology, biology, and the humanities, he brings a practical and market-aware approach to early-stage innovation, with experience in venture development, ecosystem building, and translating complex ideas for investors, partners, and non-technical audiences. He is a graduate of Georgetown's biotechnology master's program, a Marine veteran, and a cross-sector operator focused on helping founders and institutions turn strong ideas into credible, actionable opportunities.

Jennifer Butler is a distinguished global commercial executive and strategic leader with nearly 20 years of experience helping biotechnology companies move from early development through commercialization. She serves as an Entrepreneur-in-Residence with BioHealth Innovation and served as Montgomery County's first Executive-in-Residence, a role created through a collaboration between Montgomery County and BioHealth Innovation to provide technical assistance to local biotech startups. Across her career, she has brought a strong commercial perspective to emerging companies, helping founders sharpen strategy, accelerate development, and navigate the path toward growth and commercialization.

What does it take to build a biohealth ecosystem that can compete nationally? In this episode of BioTalk, Lisa Johnson, CEO of BioForward Wisconsin, discusses how Wisconsin helped shape the early use of the term "biohealth" and how that approach has supported the growth of its life sciences sector.

Lisa shares how BioForward connects industry, academia, and government to strengthen the state's ecosystem, along with key developments that have brought increased attention to the region, including the expansion of Eli Lilly and Company. She also reflects on Wisconsin's designation as a Biohealth Tech Hub through the U.S. Economic Development Administration and what it means for future growth.

The conversation highlights both momentum and ongoing challenges, particularly around access to early-stage capital and building a stronger pipeline of companies. Lisa outlines what will be required for Wisconsin to continue growing as a competitive biohealth hub.

Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com).

Lisa Johnson is the Chief Executive Officer of BioForward Wisconsin, the state's member-driven biohealth industry association dedicated to advancing Wisconsin as a global leader in biohealth innovation. In her role, she leads efforts to strengthen the state's ecosystem by connecting industry, academia, and government partners to support company growth, workforce development, and investment attraction.

Lisa brings extensive experience in economic development, public policy, and industry leadership, with a focus on building collaborative environments that drive regional competitiveness. She has been instrumental in positioning Wisconsin as a recognized biohealth hub, including leading the state's successful designation as a Biohealth Tech Hub through the U.S. Economic Development Administration. Through her work, she continues to champion initiatives that support emerging companies, expand access to capital, and foster long-term growth across the biohealth sector.

Dr. Sheetal Ajmani joins BioTalk to discuss a topic rarely addressed in the life sciences startup world. The personal and leadership toll that accompanies building and scaling a company. A physician turned executive coach and founder of Radiant Living Institute, Dr. Ajmani works closely with founders and senior leaders navigating intense professional pressure while trying to maintain clarity in decision making.

In this conversation, she explains how exhaustion and sustained stress can quietly affect leadership judgment during critical moments such as fundraising, board interactions, regulatory setbacks, and periods of rapid growth. The discussion explores the signals that investors and advisors may overlook when a founder is struggling behind the scenes, and how the culture of "pushing through" can begin to create risk not only for individuals but for the companies they lead. Dr. Ajmani also shares practical ways founders can stabilize their leadership presence and maintain momentum while protecting their own well-being.

Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com).

Dr. Sheetal Ajmani is a physician, keynote speaker, and executive coach who helps leaders and founders reclaim their well-being and lead with authenticity. After nearly two decades in clinical medicine, she founded Radiant Living Institute, where she integrates science, psychology, and the mind-body connection to help individuals make meaningful and sustainable changes in their lives and leadership. Dr. Ajmani is also the host of the Essential Self-Care podcast and co-author of the Amazon bestselling book Doctoring, Better. For more information, visit https://www.radiantlivinginstitute.com/.

Dr. Frank Peacock and Dr. Damon R. Kuehl join BioTalk for a focused discussion on one of emergency medicine's most persistent challenges: accurately diagnosing and predicting outcomes in mild traumatic brain injury. As Scientific Advisory Board members for BrainBox Solutions, Inc., they walk through what happens when a patient presents to the emergency department after a fall or sports injury and why current tools, including CT scans, often leave clinicians without clear answers. The conversation explores the gap between a "normal" scan and ongoing symptoms, and what missed or uncertain diagnoses can mean for patients weeks later.

Dr. Peacock outlines the HeadSMART II study and explains why combining blood biomarkers with neurocognitive testing provides a more complete assessment than biology alone. Dr. Kuehl discusses how multi-modal data, integrated through artificial intelligence, can generate an objective score to support real-time clinical decision-making and help identify patients at risk for persistent symptoms. The episode also highlights BrainBox's leadership, including CEO Donna Edmonds, a member of the BioHealth Innovation Board of Directors, and the company's role in advancing objective mTBI testing.

Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com).

Dr. W. Frank Peacock IV is Professor of Emergency Medicine at Baylor College of Medicine. Chief Medical Officer at AseptiScope, and the founder of both a contract research organization called Comprehensive Research Associates, LLC and a medical education company named Emergencies in Medicine, LLC. Dr. Peacock received his medical degree from Wayne State University Medical School and completed his Emergency Medicine training at William Beaumont Hospital. He has >900 peer reviewed publications and is also the co-editor of multiple medical textbooks on heart failure, acute coronary syndromes, and traumatic brain injury.

Dr. Damon R. Kuehl is the Vice Chair of Research and Academic Affairs and Professor in the Department of Emergency Medicine at Virginia Tech, School of Medicine. He completed Medical School at University of Minnesota Medical School and his Emergency Medicine Residency at Stanford University. He has also completed residencies in Preventive Medicine and a Research Fellowship in the Center for Policy and Research in Emergency Medicine, at Oregon Health and Science University. Dr. Kuehl's research primarily focuses on diagnostic and prognostic uncertainty in brain injury. He is a lead investigator for HeadSMART II and for HeadSMART Geriatrics, a NINDS funded 3 year study to develop a diagnostic tool for head trauma in older adults. He is the founder of the Carilion Brain Injury Center and also an investigator with the Virginia Tech Center for Biomechanics studying the boundary conditions associated with injuries in older adult falls.

This episode of the BioTalk with Rich Bendis Podcast brings together leaders from industry, academia, and economic development to unpack the vision behind a new life sciences Innovation District anchored in Prince William County. With introductions to NAUGEN, George Mason University's Institute for Biohealth Innovation, and the Prince William County Department of Economic Development, setting the stage for how each organization contributes to the district's foundation. The guests talk about the life science assets, research strengths, and translational capabilities that define the district and explain why it is positioned to support biotechnology and advanced R&D companies.

The conversation explores how the partnership between Prince William County, George Mason University, and the City of Manassas came together, outlining the distinct roles each plays in advancing a shared strategy. The episode also introduces the NISA program, detailing how it supports companies seeking a soft-landing pathway into the district, the types of organizations best suited for the program, and the facilities, talent, and collaborative resources participants can access both immediately and over time.

Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com).

Jaehan Park is Founder and CEO of NAUGEN, a global innovation accelerator advancing novel technologies across life sciences and deep tech. With more than 25 years of experience in strategy and business development, he has led collaborations spanning cancer immunotherapy, vaccines, and biologics with global pharmaceutical companies and academic institutions. He leads the NISA Program in partnership with George Mason University and serves as a Mentor-in-Residence at KIC DC, supporting international startups entering U.S. markets.

Amy Adams is Executive Director of George Mason University's Institute for Biohealth Innovation, where she advances biohealth research and innovation across more than 300 faculty and thousands of students. Her work focuses on partnerships, shared research infrastructure, and building hubs that connect academia with industry. She is co-leading the development of the Innovation District anchored at Mason's SciTech campus and serves on the boards of BioHealth Innovation and the Association of University Research Parks.

Christina Winn leads the Prince William County Department of Economic Development, guiding investment, business growth, and redevelopment efforts across one of Virginia's largest counties. She is overseeing the development of a research-driven Innovation District in partnership with George Mason University and the City of Manassas, supported by a GO Virginia grant. Her career includes leading large-scale economic development initiatives that have driven significant capital investment, job creation, and national visibility for the region.

IonQ Vice President and GM of Quantum Platform Matthew Keesan joins BioTalk for a clear look at how they are advancing quantum computing from its home base in the BioHealth Capital Region. He shares the story of IonQ's Maryland roots and explains quantum computing in straightforward terms for listeners seeking a high-level understanding. The conversation moves into why biohealth leaders should track the hardware race, what distinguishes IonQ's approach, and how quantum is already being paired with AI to strengthen modeling and analysis. Keesan walks through early use cases showing traction today, challenges common myths about timelines, and shares which biohealth applications he expects to gain mainstream momentum by 2030.

Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com).

Matthew Keesan is Vice President and GM of Quantum Platform at IonQ and a member of the BHI Board. He joined IonQ in 2017 to lead the development of the company's Quantum OS, the software stack that controls IonQ's quantum computers. In 2021, he oversaw the launch of IonQ's Harmony systems on Amazon Braket, Microsoft Azure Quantum, and Google Cloud, making IonQ the first quantum hardware provider available across all three hyperscalers. He built IonQ's security function to meet commercial and government frameworks, including SOC 2, NIST 800-171, NIST 800-53, and ISO 27001, and established a globally distributed operations team managing IonQ's fleet of quantum computers across the United States and Europe.

Before joining IonQ, Keesan served as CTO of the restaurant technology company Ando, which was acquired by Uber, and advised startups in manufacturing, e-commerce, and identity-as-a-service. He also helped create the technology behind the interactive HBO series Mosaic with Steven Soderbergh. He holds patents in quantum compilation, hybrid quantum computation, and quantum control automation, and has co-authored papers published in Nature and Physical Review A.

William Hurley, known widely as Whurley, joins BioTalk for a deep look at how quantum computing is moving from theory into practical use across the biohealth landscape. He opens the conversation with an introduction to Strangeworks and explains why the company is focused on making quantum computing more accessible for real-world problem-solving. The discussion explores how quantum could support breakthroughs in genomics and personalized medicine, improve the way clinical trials are modeled, and strengthen manufacturing and supply chain operations. Whurley also talks through the ingredients required for regional leadership in this space, including infrastructure, strategic partnerships, and a specialized workforce. He shares his view on what will distinguish successful players in quantum from those who overpromise or misread the market, and closes with a forward look at the convergence of quantum, AI, and biotechnology and the impact these capabilities could have on healthcare innovation. The conversation follows his recent keynote appearance at the BioHealth Capital Region Forum this past September.

Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com).

Whurley is the founder and CEO of Strangeworks, an Eisenhower Fellow, a Senior Member of the IEEE, founder of the Quantum Computing Standards Workgroup at the IEEE, the first Ambassador to CERN and Society, and co-author of "Quantum Computing for Babies" and the forthcoming "Quantum Computing for Dummies." He previously served as a Managing Director at Goldman Sachs following its acquisition of his startup Honest Dollar. Before that he founded Chaotic Moon Studios, which was acquired by Accenture.

Secretary Juan Pablo Segura joins BioTalk for a conversation about Virginia's growing position in the biohealth economy and the statewide strategy behind it. He outlines the significance of the new partnership with AstraZeneca, Lilly, and Merck, including up to $120 million in private investment to create a workforce development center and expand the Commonwealth's life sciences capacity. Segura talks through how Virginia approaches company recruitment, what investors are responding to, and why the state is seeing increased interest from biomanufacturing and advanced R&D companies. He also discusses Virginia's use of public-private partnerships to accelerate industry growth, strengthen the talent pipeline, and support emerging hubs across the Commonwealth. The conversation closes with a look at Virginia's role in the BioHealth Capital Region and how the regional identity helps amplify the state's message as it continues building a competitive biohealth ecosystem.

Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com).

Juan Pablo Segura is the Secretary of Commerce and Trade for the Commonwealth of Virginia. He leads 13 agencies focused on economic growth, business development, and industry expansion across the state. Before entering public service, Segura spent his career building companies in the digital health sector, most notably as a founder of Babyscripts, a widely adopted maternity care platform. His work has been recognized by Startup Health, CTIA, EY, and the White House. He is a CPA and a graduate of the University of Notre Dame, and he lives in Henrico, Virginia with his family.